BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25198262)

  • 1. Association of age and parity with intrauterine device expulsion.
    Madden T; McNicholas C; Zhao Q; Secura GM; Eisenberg DL; Peipert JF
    Obstet Gynecol; 2014 Oct; 124(4):718-726. PubMed ID: 25198262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age, parity, and device type on complications and discontinuation of intrauterine devices.
    Aoun J; Dines VA; Stovall DW; Mete M; Nelson CB; Gomez-Lobo V
    Obstet Gynecol; 2014 Mar; 123(3):585-592. PubMed ID: 24499755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device.
    Hinz EK; Murthy A; Wang B; Ryan N; Ades V
    Contraception; 2019 Aug; 100(2):101-105. PubMed ID: 31108053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
    Eggebroten JL; Sanders JN; Turok DK
    Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation of copper and levonorgestrel intrauterine devices: a retrospective cohort study.
    Phillips SJ; Hofler LG; Modest AM; Harvey LFB; Wu LH; Hacker MR
    Am J Obstet Gynecol; 2017 Jul; 217(1):57.e1-57.e6. PubMed ID: 28315664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of intrauterine devices among young women: a systematic review.
    Jatlaoui TC; Riley HEM; Curtis KM
    Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between intrauterine device type and risk of perforation and device expulsion: results from the Association of Perforation and Expulsion of Intrauterine Device study.
    Gatz JL; Armstrong MA; Postlethwaite D; Raine-Bennett T; Chillemi G; Alabaster A; Merchant M; Reed SD; Ichikawa L; Getahun D; Fassett MJ; Shi JM; Xie F; Chiu VY; Im TM; Takhar HS; Wang J; Saltus CW; Ritchey ME; Asiimwe A; Pisa F; Schoendorf J; Wahdan Y; Zhou X; Hunter S; Anthony MS; Peipert JF
    Am J Obstet Gynecol; 2022 Jul; 227(1):57.e1-57.e13. PubMed ID: 35395215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system.
    Simonatto P; Bahamondes MV; Fernandes A; Silveira C; Bahamondes L
    J Obstet Gynaecol Res; 2016 May; 42(5):554-9. PubMed ID: 26817571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion.
    Anthony MS; Zhou X; Schoendorf J; Reed SD; Getahun D; Armstrong MA; Gatz J; Peipert JF; Raine-Bennett T; Fassett MJ; Saltus CW; Ritchey ME; Ichikawa L; Shi JM; Alabaster A; Wahdan Y; Wang J; Xie F; Merchant M; Hunter S; Chiu VY; Postlethwaite D; Rothman KJ; Im TM; Chillemi G; Takhar HS; Asiimwe A; Pisa F
    Obstet Gynecol; 2022 Dec; 140(6):1017-1030. PubMed ID: 36357958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate postabortal insertion of intrauterine devices.
    Okusanya BO; Oduwole O; Effa EE
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD001777. PubMed ID: 25101364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective review of intrauterine device in adolescent and young women.
    Alton TM; Brock GN; Yang D; Wilking DA; Hertweck SP; Loveless MB
    J Pediatr Adolesc Gynecol; 2012 Jun; 25(3):195-200. PubMed ID: 22578480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postplacental intrauterine device expulsion by 12 weeks: a prospective cohort study.
    Goldthwaite LM; Sheeder J; Hyer J; Tocce K; Teal SB
    Am J Obstet Gynecol; 2017 Dec; 217(6):674.e1-674.e8. PubMed ID: 28826801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study.
    Bosco-Lévy P; Gouverneur A; Langlade C; Miremont G; Pariente A
    Contraception; 2019 Jun; 99(6):345-349. PubMed ID: 30871933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review.
    Foran T; Butcher BE; Kovacs G; Bateson D; O'Connor V
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):379-386. PubMed ID: 30382754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):274-9. PubMed ID: 25601352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.